INTERNATIONAL PATENT: PHRONTLINE BIOPHARMA (HANGZHOU) CO., LTD., 一线医药（杭州）有限公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY, ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF"

GENEVA, April 27 -- PHRONTLINE BIOPHARMA (HANGZHOU) CO., LTD. (Room 338, Floor 3, Building 1, 502 Linping Avenue, Donghu Steet, Linping DistrictHangzhou, Zhejiang 311103), 一线医药（杭州）有限公司 (中国浙江省杭州市临平区东湖街道临平大道502号1幢第3层338) filed a patent application (PCT/CN2025/127541) for "BISPECIFIC ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND APPLICATION THEREOF" on Oct 14, 2025. With publication no. WO/2026/082020, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application...